TY - JOUR
T1 - Muscarinic receptors in developing rat colon
AU - Zhang, Lubo
N1 - Funding Information:
This work was supported by the intramural grant from Loma Linda University School of Medicine. The author thanks Mr Jason H.S. Chang for his technical assistance, Dr Lawrence D. Longo for providing tissues, and Dr Iain L.O. Buxton for the gift of AF-DX 116.
PY - 1996/5/23
Y1 - 1996/5/23
N2 - Muscarinic receptor subtypes were characterized in fetal (21 day), newborn (3 day), and adult (3 month) rat colon smooth muscle. Saturation binding of the nonselective muscarinic antagonist radioligand [3H]quinuclidinylbenzilate revealed a single class of binding sites in all three age groups. The binding affinities of [3H]quinuclidinyl benzilate were not significantly different among three age groups (K(D): 0.19 → 0.27 nM). In contrast, the receptor densities (B(max), fmol/mg protein) showed a significant age-related decrease with fetus (518.9 ± 7.4) > newborn (480.3 ± 45.6) > adult (192.4 ± 32.8). In both newborn and adult tissues, the muscarinic agonist carbachol bound to two sites with high and low affinities. Although the agonist binding affinities in the newborn tissue were not significantly different from those in the adult tissue, the high-affinity binding sites for carbachol were significantly increased in the later (41% → 61%). Addition of guanosine-5'-O-(3-thio)triphosphate (100μM) abolished apparent high-affinity binding sites in both newborn and adult tissues. Antagonist competition binding in the newborn tissue indicated a homogeneous population of muscarinic M2 receptors. Unlike in newborn tissues, the heterogeneous binding of pirenzepine and 4-diphenylacetoxy-N-methylpiperidine methobromide in adult tissues revealed coexistence of muscarinic M3 (45%) and M2 (55%) receptors. In accordance, activation of muscarinic receptors in the adult tissue stimulated synthesis of inositol 1,4,5-trisphosphate. These results suggest maturational changes of muscarinic receptor subtypes and their coupling to G proteins in rat colonic smooth muscle. These changes may account, at least in part, for developmental alterations of functional responses in colonic smooth muscle.
AB - Muscarinic receptor subtypes were characterized in fetal (21 day), newborn (3 day), and adult (3 month) rat colon smooth muscle. Saturation binding of the nonselective muscarinic antagonist radioligand [3H]quinuclidinylbenzilate revealed a single class of binding sites in all three age groups. The binding affinities of [3H]quinuclidinyl benzilate were not significantly different among three age groups (K(D): 0.19 → 0.27 nM). In contrast, the receptor densities (B(max), fmol/mg protein) showed a significant age-related decrease with fetus (518.9 ± 7.4) > newborn (480.3 ± 45.6) > adult (192.4 ± 32.8). In both newborn and adult tissues, the muscarinic agonist carbachol bound to two sites with high and low affinities. Although the agonist binding affinities in the newborn tissue were not significantly different from those in the adult tissue, the high-affinity binding sites for carbachol were significantly increased in the later (41% → 61%). Addition of guanosine-5'-O-(3-thio)triphosphate (100μM) abolished apparent high-affinity binding sites in both newborn and adult tissues. Antagonist competition binding in the newborn tissue indicated a homogeneous population of muscarinic M2 receptors. Unlike in newborn tissues, the heterogeneous binding of pirenzepine and 4-diphenylacetoxy-N-methylpiperidine methobromide in adult tissues revealed coexistence of muscarinic M3 (45%) and M2 (55%) receptors. In accordance, activation of muscarinic receptors in the adult tissue stimulated synthesis of inositol 1,4,5-trisphosphate. These results suggest maturational changes of muscarinic receptor subtypes and their coupling to G proteins in rat colonic smooth muscle. These changes may account, at least in part, for developmental alterations of functional responses in colonic smooth muscle.
KW - colon, rat
KW - development
KW - muscarinic receptor
UR - http://www.scopus.com/inward/record.url?scp=0030598622&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0030598622&partnerID=8YFLogxK
U2 - 10.1016/0014-2999(96)00130-6
DO - 10.1016/0014-2999(96)00130-6
M3 - Article
C2 - 8813604
SN - 0014-2999
VL - 304
SP - 211
EP - 219
JO - European Journal of Pharmacology
JF - European Journal of Pharmacology
IS - 1-3
ER -